(PharmaNewsWire.Com, January 13, 2017 ) Hospital acquired bacterial infections (HABI) or nosocomial infections are type of infections commonly caused by bacterial pathogens and are acquired in healthcare facilities or hospitals. These pathogens should be examined in all patients who have developed some kind of clinical deterioration unexplained during the initial diagnosis. Currently, HABI market is a lucrative market venture due to increasing incidence rate of hospital acquired infections, which makes this industry a highly profitable and attractive market.
Some of the type of techniques and methods usually opted for performing various test for the diagnosis of hospital acquired bacterial infections are as follows: DNA Sequencing Colorimetric Methods Microarrays RT-PCR Solid-phase Hybridization Techniques Phage-based Assays The Nitrate Reductase Assay Phenotypic Methods The following are the types of hospital acquired bacterial infections: Urinary Tract Infections (UTI) Pneumonia Blood Stream Infections (BSI) Surgical Site Infections Some of the anti bacterial drug classes generally used for the treatment of HABI are as follows: Aminoglycosides B-Lactam Antibiotics Lincosamides Glycopeptides Carbapenems Macrolides Lipopeptides Polypeptides Quinolones Penicillins Sulfonamides Tetracyclines
In the geographical analysis, North America is the leading market for hospital acquired bacterial infections treatment and testing market. Due to stringent hospital regulatory policies and increased government initiatives to prevent and control various hospital-acquired infections, this region is able to maintain its dominant position across the world. Europe closely follows North America is terms of growth, due to increasing incidence of hospital-acquired infections. According to the Health Protection Agency (HPA) approximately of patients in hospitals in England acquire some form of bacterial infection during their hospital stay. However, other regions such as South East Asia, Middle East and Latin America are expected to be the promising markets in the near future. Owing to the rising disposable income among population, increasing incidence of bacterial infections and developing healthcare infrastructure, these regions are expected to be the potential market in the near future.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include North America Asia Pacific Europe Rest of the World This report provides comprehensive analysis of Market growth drivers Factors limiting market growth Current market trends Market structure Market projections for upcoming years This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report This report provides pin-point analysis for changing competitive dynamics It provides a forward looking perspective on different factors driving or restraining market growth It provides a six-year forecast assessed on the basis of how the market is predicted to grow It helps in understanding the key product segments and their future
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
